Skip to content

Evaluation of clinical effect of electromagnetic field belt in the treatment of postmenopausal osteoporosis

Investigation of the mechanisms of static magnetic fields' effects on bone remodeling based on dielectric properties and iron metabolism

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300067867
Enrollment
Unknown
Registered
2023-01-29
Start date
2023-02-01
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postmenopausal osteoporosis

Interventions

Combined magnetic field:Treatment with belt with pulse electromagnetic field and static magnetic field
Pulse electromagnetic field:Treatment with belt with only pulsed electromagnetic field
Static magnetic field:Treatment with belt with only static magnetic field
Conventional medical treatment:Conventional medical treatment

Sponsors

Honghui Hospital, Xi’an Jiaotong University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
55 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Female aged 55-70 years, natural menopause; 2. The T value of lumbar bone mineral density measured by dual-energy X-ray absorptiometry (DXA) was <= -2.5; 3. Have symptoms of low back pain; 3. The patient is informed and willing to sign the informed consent form, can better communicate in language or written form, and has good compliance.

Exclusion criteria

Exclusion criteria: 1. In the past 6 months, he has received drugs that can interfere with bone metabolism, such as glucocorticoids, calcitonin, estrogen, bisphosphate, etc; 2. Patients with thyroid disease, osteomalacia, rheumatoid arthritis, tumor, Cushing's disease, diabetes, liver and kidney dysfunction, blood system diseases and other bone metabolic diseases; 3. Removal of uterus or ovary; 4. Wearing implantable cardiac pacemaker; 5. Patients with mental disorders who cannot cooperate with the treatment research program; 6. Other researchers believe that it is not suitable for patients to participate in this study.

Design outcomes

Primary

MeasureTime frame
bone mineral density;bone turnover marker;ALP;ALP;Visual Analogue Scale (VAS) score;

Secondary

MeasureTime frame
Blood routine;

Countries

China

Contacts

Public ContactZeng Yuhong

Honghui Hospital, Xi’an Jiaotong University

xahhzyh@163.com+86 13571833516

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026